Interestingly, Huang and collaborators demonstrated that, in lung cancer, EGFR-enriched exosomes induce tDCs; tDCs, in turn, induce tumor specific Tregs, which inhibit the specific anti-tumor CTL response. The gene discussed is EGFR; the disease is neoplasm.